DANZITEN 95 mg/1
nilotinib · TABLET · Azurity Pharmaceuticals, Inc.
No Recall History
Plain English
DANZITEN is a tablet containing nilotinib at 95 mg/1, taken oral. Manufactured by Azurity Pharmaceuticals, Inc..
Key Facts
- Brand Name
- DANZITEN
- Generic Name
- nilotinib
- NDC Code (Product)
24338-155- Manufacturer
- Azurity Pharmaceuticals, Inc.
- Strength
- 95 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA219293
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 11/30/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug intolerance407 reports
drug resistance337 reports
drug ineffective333 reports
diarrhoea326 reports
dyspnoea320 reports
fatigue315 reports
nausea291 reports
headache290 reports
myalgia277 reports
arthralgia264 reports
Frequently Asked Questions
What is DANZITEN used for?
DANZITEN contains nilotinib. It is a tablet taken oral. Consult your doctor for specific uses.
Is DANZITEN a controlled substance?
DANZITEN is not classified as a controlled substance by the DEA.
What is the generic name for DANZITEN?
The generic name for DANZITEN is nilotinib. There are 10 other brand versions of nilotinib.
What is the NDC code for DANZITEN 95 mg/1?
The NDC (National Drug Code) for DANZITEN 95 mg/1 is 24338-155, listed by Azurity Pharmaceuticals, Inc..